On September 1, 2022, the Institute for Hospital Remuneration Systems (INeK) announced the start of the application process according to §6 (2) KHEntgG (New Examination and Treatment Methods, NUB) for 2023. The deadline for the submission of applications is October 31, 2022.
Germany provides a possibility for short-term, intermediate reimbursement for new and innovative technologies (NUB) to bridge the time while cost data is collected and analyzed until they can be appropriately included in the DRG system. NUB funding can be considered for devices that fully or partially constitute a new method if they are significantly more expensive than current standards and therefore do not reach full coverage through grouping with existing DRGs. Each NUB funding agreement is only valid for one year but can be renewed annually.
The full details in German can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.